Skip to content

Effect of cefotaxim on Premature Rupture of Membranes

Neonatal Complications of Premature Rupture of Membranes in Mothers Receiving Cefotaxime and Ampicillin;clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108097244N2
Enrollment
200
Registered
2016-05-27
Start date
2011-02-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature rupture of membranes. Premature rupture of membranes, unspecified

Interventions

Intervention 1: For mothers in the control group, intravenous injection of ampicillin 2 g every 6 hours (8 gram/24 hours) was started and continued until 24 hours after delivery. Intervention 2: For m
Treatment - Drugs
For mothers in the control group, intravenous injection of ampicillin 2 g every 6 hours (8 gram/24 hours) was started and continued until 24 hours after delivery.
For mothers in the intervention group, intravenous injection of cefotaxime 1 g every 8 hours (3 gram/24 hours) was started and continued until 24 hours after delivery.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Mothers with premature rupture of membrane that is required to find antibiotics? neonate alive Exclusion criteria: Six hours of onset of labor before receiving antibiotics? congenital anomaly

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Neonatal infection. Timepoint: At birth, hospitalization and discharge. Method of measurement: Questionnaiere, Physical examination.

Secondary

MeasureTime frame
Asphyxia. Timepoint: At birth. Method of measurement: Apgar Score,Atrial Blood gas.;Respiratory distress syndrom. Timepoint: hospitalization and discharge time. Method of measurement: Clinical feature, duration of hospitalization.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Najafi

Mashhad University of Medical Sciences

NajafiA881@mums.ac.ir+98 914 312 8116

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026